An overview of key information from the analysis.
of overall spend on site specific cancer research is on rare and less common cancers
0
%
drop in cancer research funding during 2020/2021
0
%
of new cancers are rare or less common
0
%
55 of cancer deaths are due to a rare or less common cancer
0
%
combined spend for site specific rare and less common cancer research in 2021
£
0
m
leading principal investigator institutions were also designated Experimental Cancer Medicine Centres (ECMCs)
0
/12
organisations found the pandemic had a negative impact in funding cancer research in the financial year 2020/21
0
%
The number of Cancer52 member organisations whose data were used in the analysis
0
The Common Scientific Outline (CSO) was used to classify the data.
Rare and less common cancers are defined as any cancer other than the four most common cancers; lung, breast, bowel and prostate.*
*Cancer Incidence. Cancer Research UK. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk#heading-Zero.